UBS Maintains Buy on Allstate, Raises Price Target to $171
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Brian Meredith has maintained a Buy rating on Allstate (NYSE:ALL) and increased the price target from $160 to $171.
January 10, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Brian Meredith reaffirmed a Buy rating on Allstate and raised the price target to $171, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Brian Meredith from UBS typically signals a strong conviction in the company's future performance and can lead to increased investor confidence. As a result, this could have a positive short-term impact on Allstate's stock price as market participants may adjust their valuations based on the new price target.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100